NIH Study Participants Willing to Share Their Experience

Mr. Elby Hudson and Mr. Tom Oden have agreed to share their experience with the media about the TACT NIH study on Chelation.

(PRWEB) January 8, 2005 -- Chelation (pronounced key-LAY-shun) therapy is an investigational therapy using a man-made amino acid, called EDTA. It is added to the blood through a vein. A national research study is now testing whether chelation therapy is safe and effective for treating heart disease.

Many people are considering using chelation therapy because of the belief that it may treat heart disease. However this has not been scientifically proven. Past studies did not show benefit, but may have been too small to be conclusive. That is why the National Institutes of Health is conducting this large study to find out whether chelation therapy is safe and effective in treating heart disease.

Where is the study taking place?
The study is taking place at more than 100 medical centers, clinics, and physicians' offices across the country. The Longevity Centre of Houston has been chosen by the NIH to serve the Houston Metro region.

For patient contact information, please contact Gurney F. Pearsall, Jr., M.D. at (713) 522-4037.

###

chelation intra venous edta nih tact national medical study infusion mi cad heart attack coronary artery disease

Bookmark -  Del.icio.us | Furl It | Technorati | Ask | MyWeb | Propeller | Live Bookmarks | Newsvine | TailRank | Reddit | Slashdot | Digg | Stumbleupon | Google Bookmarks | Sphere | Blink It | Spurl

• NIH News Advisory — Video Alert 2004-12-08
• National Study Testing Chelation Therapy For Heart Disease Under Way At Pearsall Medical & Bariatrics 2004-10-07